Manchas De Edad

Dark spots, similar to hyperpigmentation, are areas of increased pigmentation on the skin. Dark spots are generally flat and can range in color from red to brown, depending on the individual’s skin tone and the stage of healing.

DAXXIFY® is FDA approved to smooth moderate to severe lines between the brows. It is the only frown line treatment powered by a peptide. The active ingredient in DAXXIFY® is a purified protein called botulinum toxin type A.

DAXXIFY® could be for you if you would like to improve the look of your frown lines with a product that’s fast-acting, long-lasting and delivers a smooth look. Houston Dermatology and Plastic Surgery offer Daxxify. Call today to book an appointment.

DAXXIFY® is the only frown line treatment powered by a peptide. It’s fast acting, long lasting and slow to wear off.* All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, Botox® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant. DAXXIFY® is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.

In short, no, and here’s why. Units are like fingerprints—they are a proprietary measurement of a treatment’s unique potency. Because of the differences in how treatments are formulated and tested, you cannot compare or convert Units between them, just like you cannot compare 2 fingerprints. A clearer way to understand dosing is to look at how many nanograms of active ingredient (botulinum toxin type A) a product has. Double the Units does not mean double the dose.

DAXXIFY® is manufactured in California, and the only prescription frown line treatment made in the United States. Conventional frown line treatments are manufactured in other countries, then imported into the United States.

In 2002, physicians and entrepreneurs founded a start-up in Silicon Valley, California to explore the use of peptides in biologics for different therapeutic uses. Their goal was to utilize peptides to transport biologics, typically large molecules, through the skin. The initial idea was to formulate botulinum toxin type A, the active ingredient in DAXXIFY®, with a peptide to see if it could be applied topically to the skin to treat crow’s feet wrinkles. Through this process, scientists discovered that the formulation was optimally administered through injection. Several clinical studies were created to determine the correct dose for an injectable product that would treat frown lines.

DAXXIFY® was studied in the largest-ever clinical study for a frown line treatment and included more than 2,800 people across different ages and skin types

If you’re like most people, you probably get a frown line treatment around twice a year. But here’s the thing: conventional treatments only last 3–4 months. If you are not able to get treated every 3-4 months, that means you may spend the next 2-3 months of the year with those frown lines staring back at you between treatments. That’s up to 4-6 months of total wear off time per year! I

You may see results with DAXXIFY® as early as the next day after treatment, and typically within two days.